Purchase Order W9114F15P0021
- Not listed
- The U.S. Defense Health Agency awarded a $331,303.46 firm fixed-price purchase order contract to Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization based in Germany. The contract is for the provision of Matrix Assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) equipment and supplies for VITEK MS Prime non-virtual clinical and MAESTRIA PC systems, to support U.S. military medical facilities in Germany. The contract is not set aside and was awarded on May 1, 2025...
- The U.S. Department of the Army Medical Command (MEDCOM) awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Deutschland GMBH, a German-based company, on September 30, 2024. The firm fixed-price call, valued at $6,224.48, is part of a larger $2 million BPA awarded on September 20, 2022, which is designed to supply laboratory items to support U.S. military medical facilities in Europe. The BPA call involves the delivery of reagents, medical supplies, and laboratory equipment, such as...
- This is a BPA call awarded by the Department of the Army Medical Command to Biomerieux Deutschland GMBH, a German-owned for-profit company, with a potential value of $8,786.99. The contract is for the provision of medical and laboratory products and services, including VITEK microbiology systems, MALDI-TOF mass spectrometry systems, and FilmArray Torch infectious disease testing platforms, to support military medical facilities in Germany. This award is part of a larger $2 million single-award...
- This is a firm fixed-price contract awarded by the Defense Health Agency to Biomerieux Deutschland GMBH, a foreign-owned for-profit company based in Germany, to provide a lease of a Matrix Assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) mass spectrometer. The contract has a ceiling value of $412,360.03 and a period of performance from May 20, 2020 to May 19, 2025. The contract was awarded on May 20, 2020 under a full and open competition with no set-aside designation. The...
- This federal contract award, W9114F20P0003, was issued by the Defense Health Agency to Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization based in Germany. The contract, valued at $289,274.04, is for the provision of VITEK 2 ANALYZER & REAGENTS on a "COST PER REPORTABLE TEST" basis. The contract has a firm fixed price and runs through November 30, 2024. Biomerieux Deutschland GMBH is an established vendor for the U.S. military, having previously been awarded...
- This contract award is for a BPA call to Biomerieux Deutschland GMBH, a German company that provides medical and laboratory products and services to the U.S. Department of Defense. The $49,911.73 award is for "DECENTRALIZED CALLS FROM OCT23 TO JAN24" to support the U.S. Army Medical Command. Biomerieux Deutschland GMBH has previously received awards from the Army Medical Command and Defense Health Agency to supply reagents, testing equipment, and systems for military medical...
- This is a firm fixed-price contract awarded by the Department of the Army Medical Command to Biomerieux Deutschland GMBH, a German-owned for-profit organization, to provide KIT BIOFIRE GI PAN 30S. The contract has a potential value of $149,440.69 and a period of performance ending on May 22, 2019. No set-aside designation was used. Biomerieux Deutschland GMBH is a prime contractor that has received previous awards from the Army Medical Command and Defense Health Agency to supply medical and...
- Biomerieux Deutschland GMBH has been awarded a $104,466.47 firm fixed price purchase order by the Department of the Army Medical Command to deliver a VITEK 2 COMPACT system. The single award was made without any set aside provisions and carries a period of performance through October 31, 2023. Delivery is to be made to a location in Germany. This purchase is being made under an existing $2 million single award blanket purchase agreement between Biomerieux Deutschland GMBH and the Army Medical...
- The Department of the Army Medical Command awarded a $220,290 firm fixed price call against its FY23 Centralized BPA to Biomerieux Deutschland GMBH for the period of September 6-15, 2023. As a prime contractor under the Army's centralized indefinite-delivery/indefinite-quantity vehicle, Biomerieux Deutschland GMBH will provide unspecified medical products or services to support the Army Medical Command. Headquartered in Germany, Biomerieux Deutschland GMBH will perform the work under this call...
- The Department of the Army Medical Command awarded a $39,203 firm fixed price blanket purchase agreement call to Biomerieux Deutschland GMBH for decentralized calls for July 2023. Biomerieux Deutschland GMBH, located in Germany, will provide unspecified products or services to the Army Medical Command under the terms of this BPA call. No additional details were provided regarding the scope of work. The Army Medical Command manages healthcare support for soldiers and other beneficiaries around...
This federal contract award is for the lease of a MALDI-TOF mass spectrometer by the U.S. Army Medical Command (MEDCOM) to Biomerieux Deutschland GMBH, a foreign-owned, for-profit organization based in Germany. The contract, valued at $409,211.06, was awarded on April 17, 2015 with a final completion date of May 19, 2020. The contract has no set-aside designation, indicating open competition. Biomerieux Deutschland GMBH is the prime contractor on this award and has an established relationship with MEDCOM, having received multiple firm fixed-price calls totaling approximately $358,000 under two active Blanket Purchase Agreements (BPAs) with potential values of $2 million each. These BPAs, awarded in 2022 and 2024, are designed to procure laboratory items, reagents, medical supplies, and equipment in support of U.S. military medical facilities in Europe. This contract award aligns with MEDCOM's mission to support defense healthcare organizations, specifically by providing advanced medical laboratory technology and diagnostic systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $82.3k | 5/17/19 | |
| P00004 | Exercise an Option | $75.7k | 5/3/18 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 5/3/18 | |
| P00002 | Exercise an Option | $78.5k | 5/16/17 | |
| P00001 | Exercise an Option | $78.0k | 4/15/16 |